Form 4 for ANIX Anixa Biosciences Inc
Accepted 2026-07-21 10:23:18 ET · period of report 2026-07-20 · accession 0001493152-26-034027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-21 10:23 | 2026-07-20 | ANIX | KUMAR AMIT | CEO, Dir | P - Purchase | $3.46 | +5,000 | 640.8K | +0.8% | +$17.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-20 | P | A | 5,000 | $3.46 | 640,812 | D | — | — |